Amalgam Rx, Inc. — Form D/A

Amalgam Rx, Inc. of WILMINGTON, DE, a company, filed a Form D amendment with the SEC on 2019-03-06. The offering totals $2.0M, of which $998K was reported sold. Industry: Other Health Care.

Offering

Filed: 2019-03-06
Form: D/A
Accession: 0001667234-19-000002
Industry: Other Health Care
Exemptions: 06b
Total offering: $2.0M
Amount sold: $998K
Remaining: $1.0M
Investors: 20
Date of first sale: 2017-06-16
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-289825

Issuer

Name: Amalgam Rx, Inc.
CIK: 0001667234
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 206 ALAPOCAS DRIVE, WILMINGTON, DE, 19803
Phone: 302 983 0001

Officers, directors & promoters (11)

Name	Role	Location
SONNY P VU	Director	WILMINGTON, DE
JEFFREY P COURTNEY	Director	WILMINGTON, DE
Sonny Vu	Director	Tel Aviv, L3
Ryan Sysko	Director	Baltimore, MD
Ryan Sysko	Executive Officer	Baltimore, MD
Jeffrey Courtney	Director	Wilmington, DE
Ryan A Sysko	Director	Wilmington, DE
Ryan A Sysko	Executive Officer	Wilmington, DE
Sarwar A Islam	Director	Wilmington, DE
Ryan Adam Sysko	Director	Wilmington, DE
Ryan Adam Sysko	Executive Officer	Wilmington, DE

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2025-08-15	D	$7.9M	$7.9M
2023-01-03	D	$45.0M	$17.4M
2019-10-08	D	$750K	$650K
2019-05-03	D/A	$2.0M	$1.2M
2017-06-30	D	$2.0M	$95K
2016-03-24	D	$500K	$215K

More